首页> 外文期刊>Anaesthesia >A meta-analysis of prevention of postoperative nausea and vomiting: randomised controlled trials by Fujii et?al. compared with other authors
【24h】

A meta-analysis of prevention of postoperative nausea and vomiting: randomised controlled trials by Fujii et?al. compared with other authors

机译:预防术后恶心和呕吐的荟萃分析:Fujii等人进行的随机对照试验。与其他作者相比

获取原文
获取原文并翻译 | 示例
           

摘要

The population sampling in randomised controlled trials by Fujii et?al. have been shown to exhibit unusual distributions. This systematic review analysed the effectiveness of prophylactic antiemetics in trials by Fujii et?al. compared with other authors. Granisetron was more effective in trials by Fujii et?al., relative risk ratios (RRR (95% CI)): nausea 0.53 (0.42–0.67), p?=?0.00021; vomiting 0.60 (0.50–0.73), p?=?0.00094. Ramosetron was also more effective in studies by Fujii et?al.: vomiting 0.60 (0.39–0.91), p?=?0.02; nausea or vomiting 0.71 (0.56–0.91); p?=?0.006. In comparison with granisetron, droperidol was less effective in trials by Fujii et?al. than others: nausea 2.41 (1.72–3.36), p?=?2.5?×?10?7; vomiting 1.73 (1.26–2.38), p?=?6.4?×?10?4. Postoperative nausea and vomiting was less likely to trigger rescue antiemesis after granisetron and metoclopramide in studies by Fujii et?al., 0.40 (0.27–0.60), p?=?9.7?×?10?6. Triggered rates of rescue were not different in studies by others for droperidol, granisetron and metoclopramide, but were less common after granisetron than droperidol and metoclopramide in studies by Fujii et?al., 0.50 (0.38–0.66), p?=?1.7?×?10?6 and 0.47 (0.34–0.64), p?=?2.6?×?10?6, respectively. There was no synergism between antiemetics in trials by other authors. In contrast, in studies by Fujii et?al., postoperative nausea and vomiting was more likely if granisetron was administered alone: nausea 4.20 (1.94–9.08), p?=?2.6?×?10?4; vomiting 4.50 (2.55–7.97), p?=?2.3?×?10?7; nausea or vomiting 5.00 (2.84–8.81), p?=?2.5?×?10?8. Similarly, droperidol was less effective in studies by Fujii et?al. if administered alone: vomiting 2.76 (1.25–6.11), p?=?0.01; nausea or vomiting 2.96 (1.46–6.00), p?=?2.7?×?10?3. The conclusion is that if, as recommended, data with unusual distributions are removed from meta-analysis and articles by Fujii et?al. excluded, then the antiemetic effects of granisetron and ramosetron are greatly reduced; further, there is no evidence of synergism between antiemetics and indeed, some evidence of antagonism between antiemetic agents.
机译:藤井等人的随机对照试验中的人群抽样。已显示出异常的分布。该系统评价分析了Fujii等人在试验中使用预防性止吐药的有效性。与其他作者相比。在Fujii等人的试验中,Granisetron更有效,相对风险比(RRR(95%CI)):恶心0.53(0.42-0.67),p?= 0.00021;呕吐0.60(0.50–0.73),p?=?0.00094。 Ramosetron在Fujii等人的研究中也更有效:呕吐0.60(0.39–0.91),p?=?0.02;恶心或呕吐0.71(0.56-0.91); p≥0.006。与Granisetron相比,Fujii等人在试验中氟哌啶的效果较差。比其他人:恶心2.41(1.72-3.36),p?=?2.5?×?10 ?7 ;呕吐1.73(1.26-2.38),p?=?6.4?×?10 ?4 。藤井等人的研究表明,术后发生恶心呕吐和格拉司琼和甲氧氯普胺合用后,更容易引发抢救性呕吐,为0.40(0.27–0.60),p == 9.7?×?10 ?6 。在其他研究中,氟哌利多,格拉司琼和胃复安的触发挽救率没有差异,但在Fujiise等人的研究中,格拉司琼治疗后的挽救触发率比氟哌利多和胃复安的少见,为0.50(0.38–0.66),p == 1.7? ×?10 ?6 和0.47(0.34-0.64),p?=?2.6?×?10 ?6 。在其他作者的试验中,止吐药之间没有协同作用。相反,在藤井等人的研究中,如果单独使用格拉司琼,则术后恶心和呕吐的可能性更高:恶心4.20(1.94–9.08),p?=?2.6?×?10 ?4 ;呕吐4.50(2.55-7.97),p?=?2.3?×?10 ?7 ;恶心或呕吐5.00(2.84-8.81),p?=?2.5?×?10 ?8 。类似地,Fujii等人的研究中氟哌啶无效。如果单独服用:呕吐2.76(1.25–6.11),p = 0.01。恶心或呕吐2.96(1.46-6.00),p?=?2.7?×?10 ?3 。结论是,如果按照建议,Fujii等人从荟萃分析和文章中删除了具有异常分布的数据。如果排除,则格拉司琼和雷莫司琼的止吐作用大大降低;此外,没有证据表明止吐药之间存在协同作用,确实没有证据表明止吐药之间存在拮抗作用。

著录项

  • 来源
    《Anaesthesia》 |2012年第10期|1076-1090|共15页
  • 作者

    J. B. Carlisle;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号